Skip to main content
Advanced Technical IVT

tumor regression grade

Also written as: TRG — Tumor Regression Grade

Histopathological assessment quantifying tumor response to neoadjuvant therapy, ranging from complete response to no response.

Full Definition

Tumor regression grade (TRG) is a standardized pathological scoring system that evaluates the degree of tumor response to preoperative chemotherapy or chemoradiation therapy. The grading system typically ranges from complete pathological response (no viable tumor cells) to minimal or no response (abundant viable tumor remaining). TRG assessment is particularly important in rectal cancer, esophageal cancer, and breast cancer management, as it provides prognostic information and helps validate the effectiveness of neoadjuvant treatment protocols. Different TRG systems exist, with the most common being the Mandard system and the American Joint Committee on Cancer system.

Usage

Usage note: Specify which TRG system is being used (Mandard, AJCC, etc.).

In Context

  • "The pathology report showed tumor regression grade 2 with moderate response to neoadjuvant chemoradiation." — histopathology assessment
  • "Excellent tumor regression grade correlated with improved long-term survival outcomes in the clinical trial." — research publication

Also known as

TRG pathological response assessment

Don't confuse with

pathological complete response tumor grade

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON